Early continuous hypertonic saline infusion to improve 6-month neurological outcome after traumatic brain injury
Official title: Efficacy of Early Continuous Infusion of Hypertonic Saline Solution on the Neurological Outcome at 6 Months in Traumatic Brain Injured Patients. A Single-blinded, Multicenter, Randomized, Controlled Clinical Trial With Blinded Evaluation of the Primary Outcome.
Run by Nantes University Hospital · NCT07319208 · Data updated 2026-11-12
This trial will test whether giving a continuous intravenous infusion of hypertonic saline early after traumatic brain injury helps people survive and regain independence in daily life at 6 months.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 760 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 23 sites (Angers and 22 other locations) |
| Status | Recruiting |
| Started | April 21, 2026 |
| Main results expected | June 1, 2028 |
| Study ends | June 1, 2029 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT07319208 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ICU patients with traumatic brain injury and Glasgow Coma Scale ≤ 12 who undergo intracranial pressure monitoring and can be enrolled within 12 hours of monitor placement, with appropriate consent and French national health insurance.
✕Probably not a fit
Patients unlikely to benefit include those with unsurvivable injury (GCS 3 with persistent nonreactive pupils despite treatment), coma from cardiac arrest, major spinal cord injury, or severe cardiac, renal, or hepatic failure, and pregnant patients who are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase 3 interventional trial enrolls intensive care patients with traumatic brain injury at high risk of intracranial hypertension who have intracranial pressure monitoring. Participants receive an early continuous intravenous infusion of hypertonic saline solution, started within the first 12 hours after ICP monitor placement, and are followed for clinical outcomes. The primary focus is on survival and independence in daily activities at 6 months. The trial is led by Nantes University Hospital and conducted at multiple French university hospitals.
Why it matters
Potential benefit: If successful, this approach could increase survival and improve functional independence at six months for patients with traumatic brain injury and high risk of intracranial hypertension.
How similar studies have gone: Hypertonic saline is widely used to lower intracranial pressure and short-term studies show benefit for ICP control, but strong phase 3 evidence showing improved long-term functional outcomes is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient admitted to intensive care unit * Traumatic brain injury with Glasgow Coma Scale ≤ 12 * Intracranial pressure (ICP) monitoring based on the attending physician's clinical judgment, in accordance with guidelines or clinical/radiological signs considered at risk of intracranial hypertension * Inclusion during the first 12 hours after Intracranial pressure monitoring placement * Informed and signed consent * National health insurance Exclusion Criteria: * Glasgow Coma Scale (score = 3) and persistent abnormal pupillaryreactivity despite urgent therapy * Associated cervical spinal cord injury * Imminent death and do-not-resuscitate orders * Coma secondary to cardiac arrest * Pregnancy (serum or urine test performed in routine care) * Severe Cardiac insufficiency * Severe chronic renal insufficiency * Severe hepatic insufficiency: patient presenting with oedemato-ascitic decompensation of liver cirrhosis or patient with Child-Pugh class C cirrhosis * High risk of follow-up difficulties after ICU discharge * Patients under court protection * Patient who does not speak French
Where it's running
-
CHU de Brest
Brest, France Recruiting -
CHU Caen Normandie
Caen, France Recruiting -
CHU de Clermont- Ferrand
Clermont-Ferrand, France Recruiting -
Hôpital BEAUJON APHP
Clichy, France Recruiting -
CHU Henri Mondor APHP
Créteil, France Recruiting -
CHU de Lille
Lille, France Recruiting
Show 17 more locations
-
CHU de Nantes
Nantes, France Recruiting -
CHU de Nice
Nice, France Recruiting -
CHU de Rennes
Rennes, France Recruiting -
CHU de Toulouse
Toulouse, France Recruiting -
CHU d'Angers
Angers, France Not yet recruiting -
CH de Annecy Genevois
Épagny, France Not yet recruiting -
CHU de Grenoble
Grenoble, France Not yet recruiting -
Hcl
Lyon, France Not yet recruiting -
Ap-Hm
Marseille, France Not yet recruiting -
CHU de Nancy
Nancy, France Not yet recruiting -
CHU Lariboisière, AP-HP
Paris, France Not yet recruiting -
GHU Paris Cité
Paris, France Not yet recruiting -
CHU de Poitiers
Poitiers, France Not yet recruiting -
CHU de Rouen
Rouen, France Not yet recruiting -
CHU de St- Etienne
Saint-Etienne, France Not yet recruiting -
CHU de Strasbourg
Strasbourg, France Not yet recruiting -
CHRU de Tours
Tours, France Not yet recruiting
Study contacts
- Study coordinator: Antoine ROQUILLY
- Email: antoine.roquilly@chu-nantes.fr
- Phone: +33 2 53 48 22 30
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Fibrinogen-to-Albumin Ratio as a Predictor of ARDS in Traumatic Brain Injury
This study tests whether the fibrinogen-to-albumin ratio can predict who among adults with traumatic brain injury will develop acute respiratory distress syndrome (ARDS).
-
Support-TBI: Testing a partner-based program to help people with traumatic brain injury stay connected
A small pilot test will see if a partnered person with TBI and a close supporter can successfully participate in a 12-week program to improve social support and daily life participation.
-
ENGAGE-TBI: A Feasibility Program to Reduce Social Isolation for Adults with Traumatic Brain Injury
We’re testing a 12-session group program to help adults with traumatic brain injury in the community build social participation and reduce isolation.
-
Can a bedside brain scan (fNIRS) detect activity in healthy people and in people with disorders of consciousness
This observational study tests whether functional near-infrared spectroscopy (fNIRS) can measure brain activity at the bedside in healthy adults and in patients with disorders of consciousness in the Neuro-ICU.
-
Long-lasting effects of hyperbaric oxygen therapy on thinking after traumatic brain injury
This project will see if people with traumatic brain injury who completed a course of hyperbaric oxygen therapy 1–4 years ago still have improved thinking and memory.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.